{"acquisitions":[],"changes":[],"country":"US","description":"MapLight Therapeutics is a clinical-stage biotech applying circuit-level neuroscience to develop targeted treatments for brain and nervous system disorders. It serves patients with conditions including schizophrenia and Alzheimer's psychosis, led by ML-007C-MA. Its platform combines optogenetics and transcriptomics to pinpoint misfiring circuits.","domain":"maplightbio.com","employees":null,"founded":2016,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":37.389389,"lng":-122.08321,"location":"Mountain View","multiples":[],"name":"MapLight Therapeutics","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":372500000,"connectionsAmong":[],"currency":"USD","date":"2025-07-15","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"maplightbio-com-2025-07-15-series-b","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-26","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"maplightbio-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-26","status":"attributed","url":null},{"fact":"existence","publisher":"maplightbio.com","retrievedAt":"2026-05-26","status":"self-reported","url":"https://maplightbio.com"},{"fact":"description","publisher":"maplightbio.com","retrievedAt":"2026-05-26","status":"self-reported","url":"https://maplightbio.com"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":[],"totalRaisedUsd":500000000,"traction":[],"updatedAt":"2026-05-26","valuations":[]}